News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresenius Kabi USA Launches Treatment for Acetaminophen Overdose


1/8/2013 9:58:31 AM

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA, LLC today announced the launch of Acetylcysteine Injection. The product is indicated to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES